BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31948545)

  • 1. Generating stem-like memory T cells with antioxidants for adoptive cell transfer immunotherapy of cancer.
    Pilipow K; Scamardella E; Lugli E
    Methods Enzymol; 2020; 631():137-158. PubMed ID: 31948545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity.
    Pilipow K; Scamardella E; Puccio S; Gautam S; De Paoli F; Mazza EM; De Simone G; Polletti S; Buccilli M; Zanon V; Di Lucia P; Iannacone M; Gattinoni L; Lugli E
    JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.
    Alvarez-Fernández C; Escribà-Garcia L; Vidal S; Sierra J; Briones J
    J Transl Med; 2016 Jul; 14(1):214. PubMed ID: 27435312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of Diverse Progenies of Memory T Cells from Naïve CD8
    Zanon V; Lugli E
    Methods Mol Biol; 2017; 1514():103-110. PubMed ID: 27787795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient stimulation expands superior antitumor T cells for adoptive therapy.
    Kagoya Y; Nakatsugawa M; Ochi T; Cen Y; Guo T; Anczurowski M; Saso K; Butler MO; Hirano N
    JCI Insight; 2017 Jan; 2(2):e89580. PubMed ID: 28138559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy.
    van der Waart AB; van de Weem NM; Maas F; Kramer CS; Kester MG; Falkenburg JH; Schaap N; Jansen JH; van der Voort R; Gattinoni L; Hobo W; Dolstra H
    Blood; 2014 Nov; 124(23):3490-500. PubMed ID: 25336630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
    Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
    Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curtailed T-cell activation curbs effector differentiation and generates CD8
    Zanon V; Pilipow K; Scamardella E; De Paoli F; De Simone G; Price DA; Martinez Usatorre A; Romero P; Mavilio D; Roberto A; Lugli E
    Eur J Immunol; 2017 Sep; 47(9):1468-1476. PubMed ID: 28671275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK inhibition reprograms CD8
    Verma V; Jafarzadeh N; Boi S; Kundu S; Jiang Z; Fan Y; Lopez J; Nandre R; Zeng P; Alolaqi F; Ahmad S; Gaur P; Barry ST; Valge-Archer VE; Smith PD; Banchereau J; Mkrtichyan M; Youngblood B; Rodriguez PC; Gupta S; Khleif SN
    Nat Immunol; 2021 Jan; 22(1):53-66. PubMed ID: 33230330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8
    Hermans D; Gautam S; García-Cañaveras JC; Gromer D; Mitra S; Spolski R; Li P; Christensen S; Nguyen R; Lin JX; Oh J; Du N; Veenbergen S; Fioravanti J; Ebina-Shibuya R; Bleck C; Neckers LM; Rabinowitz JD; Gattinoni L; Leonard WJ
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6047-6055. PubMed ID: 32123114
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Hu X; Majchrzak K; Liu X; Wyatt MM; Spooner CJ; Moisan J; Zou W; Carter LL; Paulos CM
    Cancer Res; 2018 Jul; 78(14):3888-3898. PubMed ID: 29769201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model.
    Contreras A; Beems MV; Tatar AJ; Sen S; Srinand P; Suresh M; Luther TK; Cho CS
    J Immunother Cancer; 2018 May; 6(1):41. PubMed ID: 29843822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
    Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
    Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients.
    Casati A; Varghaei-Nahvi A; Feldman SA; Assenmacher M; Rosenberg SA; Dudley ME; Scheffold A
    Cancer Immunol Immunother; 2013 Oct; 62(10):1563-73. PubMed ID: 23903715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell like memory T cells: A new paradigm in cancer immunotherapy.
    Wang F; Cheng F; Zheng F
    Clin Immunol; 2022 Aug; 241():109078. PubMed ID: 35840054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity.
    Hinrichs CS; Borman ZA; Cassard L; Gattinoni L; Spolski R; Yu Z; Sanchez-Perez L; Muranski P; Kern SJ; Logun C; Palmer DC; Ji Y; Reger RN; Leonard WJ; Danner RL; Rosenberg SA; Restifo NP
    Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17469-74. PubMed ID: 19805141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
    Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
    Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.
    Crompton JG; Sukumar M; Restifo NP
    Immunol Rev; 2014 Jan; 257(1):264-276. PubMed ID: 24329803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory.
    Saito H; Okita K; Chang AE; Ito F
    Cancer Res; 2016 Jun; 76(12):3473-83. PubMed ID: 27197199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.